You just clicked a link to go to another website. If you continue, you will leave this site and go to a site run by someone else.
Medtronic does not review or control the content on the other website, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in the Indian Subcontinent.
Any and all information provided is intended for general overview. Viewers taking any decision based on the information provided herein are requested to seek professional advice.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations.
Click “OK” to confirm you are a Healthcare Professional.
On June 25, 2019, Medtronic notified customers of potential cybersecurity risk in the MiniMed™ 508 and MiniMed™ Paradigm™ series of insulin pumps; these models are from 2012 and earlier. An unauthorized person with special technical skills and equipment could potentially connect wirelessly to a nearby insulin pump to change settings and control insulin delivery. At this time, we have not received any confirmed reports of unauthorized persons changing settings or controlling insulin delivery. Medtronic provided its customers and their doctors with recommended security precautions when using their insulin pump. These include paying attention to any pump notifications, alarms and alerts apart from others. Kindly note that the insulin pumps are not being recalled and are not required to be returned. This is a safety notification only.
In India, Medtronic is proactively informing the regulators and other relevant stakeholders and in the process of working with researchers, doctors and patients to address any questions or concerns that they may have. No patient issues have been reported in India so far. MiniMed™ 508 had been discontinued in India since 2011. Over the years, we’ve launched many advanced models of insulin pumps and they are safe for patients. At Medtronic, we take quality concerns with the utmost seriousness, and the safety of patients is our primary concern. As technologies evolve, we will continue to collaborate with industry researchers and regulators to improve device security approaches and develop high-quality therapies that positively impact lives.